• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    High Drug Loading Amorphous Solid Dispersions

    Parenteral Drug Delivery Trends

    Selecting the Right Outsourcing Model for Emerging Biotech

    Inhaled Drug Delivery Technology

    The Future of Biologics: Accelerating Production, Reducing Costs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Spark Therapeutics Appoints CTO

    Cryoport Launches ESG Program

    U.S. Govt. Purchases 100k Doses of Lilly's COVID-19 Antibody Cocktail

    Thermo Fisher Scientific Completes Mesa Biotech Acquisition

    Ashfield Engage, Popit Form Digital Monitoring Collaboration
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Solid Dose Market Trends

    CatSci Opens New Site in UK

    Pfizer Partners with Medicines Manufacturing Innovation Center

    C2 Pharma Completes Multiple Regulatory Filings

    Bormioli Opens New Glass Research Center
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Covectra Introduces Next-Gen Serialization Solution

    Bormioli Opens New Glass Research Center

    Centrient Pharmaceuticals to Acquire Astral SteriTech

    Seasonal Vaccine Manufacturing

    PwC Joins Medicines Manufacturing Innovation Centre
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Ashfield Engage, Popit Form Digital Monitoring Collaboration

    AMRI Contributes to Efforts to Increase COVID-19 Vax Supply

    CatSci Opens New Site in UK

    Pfizer Partners with Medicines Manufacturing Innovation Center

    CrownBio & JSR Life Sciences Partner with Cambridge Quantum Computing
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Alcami

    PCI Pharma Services

    Reed-Lane

    Adare Pharma Solutions

    test company saurabh
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    PCI Pharma Services

    Syngene

    Aphena Pharma Solutions

    Emergent BioSolutions

    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Effective Project Management

    Creating opportunities for lower costs and faster time-to-market

    Related CONTENT
    • G-CON Manufacturing Delivers & Installs PODs for Cell Therapy Manufacturing
    • Intravacc Unveils New Pilot Vaccine Production Facility
    • Inside a Vaccine Trial
    • Virtual Clinical Trials: The Future of Dermatology Studies
    • Advancing Digital Endpoints in Clinical Trials
    Peter Soelkner09.03.09

    Effective Project Management



    Creating opportunities for lower costs and faster time-to-market



    By Peter Soelkner



    The squeeze is on. The cost of development, discovery and manufacturing of new drugs is continuously rising. Economic realities are forcing pharmaceutical and biotechnology companies to be on the lookout for an enduring solution to meet market challenges and control development and manufacturing costs.

    Moreover, to control costs, streamline the development cycle and maximize their return on investment, many pharmaceutical companies are embracing collaboration with CMOs. While these productive partnerships offer significant value-added benefits, they also open a new set of challenges.

    A drug’s time-to-market can take years, and there is no guarantee it will succeed, no matter how much research, effort and financial resources are ultimately invested in a product. In addition, pharmaceutical and biotech companies continue to face increasing market challenges, including stringent regulatory standards, strict quality control criteria and stronger global competition. These issues can make effective communication increasingly difficult between the stakeholders of the pharmaceutical company and their collaborative CMO. Can all of these challenges be addressed — and solved — to make contract manufacturing a worthwhile pursuit?

    Through effective project management and industry experience, the answer is “yes.” Project management for drug development is a highly specialized and relatively new practice. But with the right project management process in place, companies can drastically reduce a product’s time-to-market, cut their costs and increase their RoI. First, however, they must select a CMO that can prove its project management prowess.

    A Healthy Start



    Regardless of the industry, project management typically addresses several universal steps: initiation, planning and coordination, controlling, and closing. In the pharmaceutical industry, these steps are increasingly more complicated, and the risks involved with drug research, discovery and development must be taken into account from the very beginning.

    To ensure a successful partnership, pharmaceutical and biotechnology companies must engage a CMO that can fulfill their needs to provide a streamlined turn-key approach that reduces a drug’s time-to-market. Eager to win business in today’s competitive environment, some CMOs will submit unreasonably low project estimates. This practice often leads to the CMO cutting corners to control costs, putting the entire project at risk.

    Mitigating these risks requires a thorough upfront analysis of the entire project. From formulation to packaging and more, specifications of each aspect of the project — as well as the product’s specific attributes — must be discussed. Therefore, it is very helpful to start a relationship with the CMO in the early development phase (preclinical / Phase I).

    It’s also beneficial to consider a CMO that abides by the standards set forth by a valued industry resource, such as the International Project Management Association (IPMA), a non-profit organization that represents 45 national project management associations on the international level.

    In addition to establishing testing processes that ensure project managers are prepared for the tasks that lie ahead, IPMA facilitates best practice models that are used in quality project management procedures. These include management processes, methods, techniques, tools and functions that help boost efficiency by keeping a project on schedule and within budget.

    The Right Team



    Once a CMO with the experience and capacity to successfully complete the project has been selected, the real work begins. To ensure an effectively managed project, a project manager must be designated by each partner organization. The project manager should:
    • Demonstrate a background in natural sciences;
    • Show professional experience working with and managing teams that include scientists and manufacturing specialists;
    • Offer significant soft skills, such as leadership, negotiation skills and public speaking

    Once project managers have been chosen, the selection of members for each organization’s project team is critical. The CMO must be prepared to address and solve all existing and potential issues throughout the entire development and production process. To ensure a streamlined process, the CMO’s team should include members with expertise in:
    • Packaging
    • Development
    • Process development
    • Qualification and validation
    • Production
    • Regulatory affairs
    • Quality management
    • Supply chain management

    To maintain continuity and ensure effective communication, the pharmaceutical company’s project management team should mirror the CMO’s team. A steering committee, comprised of senior managers from both companies, should be developed to serve as an interface between the two companies, keep the teams abreast of the project’s progress and make critical decisions regarding investments, timelines and other key issues.

    Creating the Plan



    Investing resources in careful and detailed planning in the earliest phases of a project results in rapid project implementation and the ability to properly plan for potential issues throughout the initial product launch, if not throughout the entire lifecycle of the drug.

    Proper planning includes providing each team member, from both the pharmaceutical company and the CMO, the opportunity to submit questions to the group based on each member’s own functional expertise. The use of a standardized questionnaire is an effective tool that can act as a guide throughout all project phases. Consider an example of a drug that is delivered via a pre-filled syringe. The questionnaire might ask:
    • Is the active substance incompatible with any materials commonly used in packaging?
    • How much silicon is required for the plunger to move smoothly?
    • Is the substance sensitive to oxygen?

    A well-versed CMO will have the knowledge and experience to ask more detailed questions to uncover pitfalls early on in the process. By thoroughly investigating each and every question, serious delays and problems can be avoided in the later stages of the project. Potential changes should also be taken into account in case the process itself creates new and unforeseen situations.

    Following review of the questionnaire, the CMO should outline the plan step-by-step to:
    • Clearly define project goals
    • Create well-defined workpackages and responsibilities
    • Identify critical activities and milestones
    • Design and analyze production processes and procedures and develop a complete risk analysis
    • Share all data and project information with members of both teams
    • Remain flexible and willing to adjust the process if the situation warrants

    Partnering with an experienced CMO that understands where potential problems lie will expedite the planning process and reduce the drug’s overall time-to-market.

    Embracing ERP



    Successful project management includes the utilization of effective technology systems. In most cases, Enterprise Re-source Planning (ERP) software offers solutions to:
    • Collate information from existing catalogues
    • Calculate and describe resources critical to the project
    • Track costs
    • Divide the project into individual phases for easy tracking (project gates)

    To maintain time and budget goals, the CMO’s project manager should review ERP reports monthly at a minimum. In addition to staying on course, this will allow the project to be adjusted to current situations if needed.

    Opening the Channels of Communication



    Effective communication and sharing of information is a key element and should flow freely between all stakeholders throughout every phase of the project. Such dialogue prevents failures due to misunderstandings, lack of information, erroneous interpretation and overlooked risks, and creates a positive project relationship between the two partners and all team members.

    To ensure each party is fully aware of a project’s progress and informed of any potential roadblocks, the project managers from both organizations should schedule and facilitate weekly conference calls and/or project management meetings to track accomplishments and missteps, as well as to determine any required solutions. This will ensure the project is being handled properly and communication channels are open.

    The project managers should also document and distribute regularly scheduled reports on centralized platforms, such as Internet share points, to ensure all teams are abreast of the latest project information. Internal and external access, combined with conclusive and traceable documentation through the process development and implementation phases, are essential for maintaining a seamless communication flow.

    In addition to open communication channels, each project requires a well-thought-out communication tree. What if a decision needs to be made urgently, yet is beyond the project manager’s scope? The entire steering committee should be assembled to address the issue. If a resolution is needed even faster, each organization’s regular hierarchy must be approached.

    From Planning to Realization



    Once the playbook has been written and the experts have molded into a strong project team, work can begin. During the development and validation phases, work packages outlined in the plan are transformed into a tangible product. The project manager continues to play a critical role in this phase, closely monitoring project needs and overall costs to avoid delays, manage crises and ensure the project remains on track based on tactics developed during the planning phase.

    To avoid unnecessary delays or expenses, the project management team must carefully plan and constantly track the project’s progress. Knowledge transfer and open communication are crucial during this particular phase in the process. To assure this, well-defined milestones and project gates at the end of critical or important project phases have to be established to control and review the project progress against the plan for:
    • Quality of achieved objectives / work packages
    • Needed resources / cost
    • Time to market

    Crisis management is especially important during this final phase as a crisis can have serious impact on an organization’s reputation and can drastically affect customer confidence. Pharmaceu-tical companies are already faced with increasing production costs, intensifying global competition and growing regulatory stringency. Each project will have its own issues and challenges. Establishing a strong crisis management plan allows the project manager to control many situations and minimize or even avoid possible negative impact that results from unfavorable situations.

    At the end of a project the team will conduct a thorough project review and develop lessons learned that may help improve future projects.

    A Successful Conclusion



    Pharmaceutical project management is a complex issue, but successful outcomes are consistently possible with the right elements in place. Key components include:
    • A strong management commitment from the very beginning;
    • An understanding of product-specific needs, process know-how and proven project management skills;
    • A well-structured approach in all project phases;
    • Project tools for Planning and Controlling;
    • Conclusive and traceable documentation through process development and implementation;
    • Identification and quick follow-up on critical project tasks

    A careful and detailed approach can make a significant difference in the outcome of a drug’s success by saving time and money while improving results. Each project must be managed within its own set of circumstances. And a CMO that understands its uniqueness can make all the difference in the world.

    Peter Soelkner is managing director of Vetter Pharma International GmbH.
    Related Searches
    • Manufacturing
    • Regulatory Affairs
    • Process Development
    • Pharma
    Suggested For You
    G-CON Manufacturing Delivers & Installs PODs for Cell Therapy Manufacturing G-CON Manufacturing Delivers & Installs PODs for Cell Therapy Manufacturing
    Intravacc Unveils New Pilot Vaccine Production Facility Intravacc Unveils New Pilot Vaccine Production Facility
    Inside a Vaccine Trial Inside a Vaccine Trial
    Virtual Clinical Trials: The Future of Dermatology Studies Virtual Clinical Trials: The Future of Dermatology Studies
    Advancing Digital Endpoints in Clinical Trials Advancing Digital Endpoints in Clinical Trials
    Life Sciences Strive for Greater Agility Life Sciences Strive for Greater Agility
    Tubulis, WuXi Biologics and WuXi STA Form Strategic Pact Tubulis, WuXi Biologics and WuXi STA Form Strategic Pact
    Asymchem Asymchem
    Novavax Makes Leadership Changes Novavax Makes Leadership Changes
    INCOG BioPharma Launches Central Indiana Ops INCOG BioPharma Launches Central Indiana Ops
    The Changing Approach to Design: Five Ways to Achieve Warp Speed The Changing Approach to Design: Five Ways to Achieve Warp Speed
    Vetio Animal Health Vetio Animal Health
    CMO Selection Criteria CMO Selection Criteria
     Vantage Consulting is First Systems Integrator to Join PBOA Vantage Consulting is First Systems Integrator to Join PBOA
    Newsmakers: Peter Soelkner Newsmakers: Peter Soelkner

    Related Features

    • Biologics, Proteins, Vaccines | Biosimilars | Drug Development
      Biopharma Contract Manufacturing: Robust Growth Ahead

      Biopharma Contract Manufacturing: Robust Growth Ahead

      The biopharmaceutical contract manufacturing market is projected to reach $6.3 billion in 2020, and it will continue to grow over the next five years.
      William Downey, HighTech Business Decisions 11.17.20

    • Drug Development | Drug Discovery | R&D
      R&D Outsourcing Trends

      R&D Outsourcing Trends

      Highly specialized drug products and capacity needs drive increased reliance on contract service providers.
      Kristin Brooks, Managing Editor, Contract Pharma 10.14.20

    • Drug Development | Preclinical Outsourcing
      Preclinical Planning for Successful Drug Development

      Preclinical Planning for Successful Drug Development

      When the preclinical pressure is on, appropriate planning can make sure timelines are achievable.
      Mingyi Trimble, WuXi AppTec 09.09.20


    • APIs | Drug Development | Risk Management
      Small-Molecule Drug Development: Advantages of an Integrated, Phase-Based Approach

      Small-Molecule Drug Development: Advantages of an Integrated, Phase-Based Approach

      Small-molecule drug development has become more complex and challenging, leading to greater reliance on CDMOs.
      Sarah Bethune, Cambrex 09.09.20

    • Biologics, Proteins, Vaccines | Drug Development | Regulatory Affairs
      Expediting a COVID-19 Vaccine: FDA Approval Process

      Expediting a COVID-19 Vaccine: FDA Approval Process

      The pressures of the pandemic are pushing sponsors and FDA to look at both efficacy and speed in developing a vaccine.
      Kristin Brooks, Managing Editor 09.09.20

    • Drug Development | Regulatory Affairs
      Guidelines in Toxicology: A Blessing and a Curse

      Guidelines in Toxicology: A Blessing and a Curse

      A look at the evolution of drug development regulatory guides.
      Sarah Gould, Senior Principal Scientific Advisor, Charles River 09.16.19


    • Drug Development
      Flex Your Outsourcing Model to Maximize Drug Development

      Flex Your Outsourcing Model to Maximize Drug Development

      How to choose—and optimize—combinations of service models to fit your needs.
      Timothy King, Executive Director, Functional Service Partnerships (FSP), PPD 09.16.19

    • Biologics, Proteins, Vaccines | Drug Delivery | Drug Development
      Knowledge Sharing: Biologics Development and Delivery

      Knowledge Sharing: Biologics Development and Delivery

      The increasing importance of sharing information to build awareness and better manage the complexities of drug development.
      Fran L. DeGrazio, Vice President of Scientific Affairs and Technical Services, West Pharmaceutical Services 09.16.19

    • Drug Development
      Improving Your Development Program

      Improving Your Development Program

      Seven lab science trends driving the future of drug development.
      Jenifer Vija, Liam Moran, Chris Loosbroock and Eric Snyder, Charles River 05.07.19


    • Drug Development
      Technical Advantages of Continuous Flow Chemical Synthesis

      Technical Advantages of Continuous Flow Chemical Synthesis

      Continuous flow chemistry is known for its ability to handle hazardous reactions safely, but can also unlock many other technological benefits.
      Shawn Conway, Engineering R&D Director, Cambrex High Point 04.05.19

    • Drug Development | Preclinical Outsourcing
      Early Development Trends

      Early Development Trends

      Catalent’s president of oral drug delivery, Jonathan Arnold, talks trends and challenges in the early phases of drug development.
      Tim Wright, Editor, Contract Pharma 03.06.19

    • Drug Development
      Future Trends in the CDMO Space

      Future Trends in the CDMO Space

      And how to navigate them for successful drug development
      Guillaume Plane, Global Development and Marketing Manager, BioReliance End-to-End Solutions, MilliporeSigma 01.25.19


    • APIs | Cytotoxics and High Potency Manufacturing | Drug Development
      CDMOs On The Rise

      CDMOs On The Rise

      Tracking growth and strategies in the CDMO business
      Michel Le Bars, Managing Partner, Kurmann Partners AGe 01.25.19

    • Drug Development | Formulation Development
      Abuse Deterrent Formulations

      Abuse Deterrent Formulations

      A look at opioid abuse in North America and formulations to help avoid an epidemic.
      Damon Smith, Richard Dart and Christopher Hirst 11.13.18

    • Drug Development
      Streamlining Drug Development:

      Streamlining Drug Development:

      Four key takeaways from Veeva’s 2018 R&D Summit
      Henry Levy, General Manager of Vault CDMS, Veeva Systems 11.13.18

    Trending
    • Pfizer Selects Seven Bridges To Support RNA Sequencing Data
    • Pfizer Partners With Medicines Manufacturing Innovation Center
    • Catalent Acquires Delphi Genetics
    • Charles River Acquires CDMO Cognate BioServices
    • Spark Therapeutics Appoints CTO
    Breaking News
    • Spark Therapeutics Appoints CTO
    • Cryoport Launches ESG Program
    • U.S. Govt. Purchases 100k Doses of Lilly's COVID-19 Antibody Cocktail
    • Thermo Fisher Scientific Completes Mesa Biotech Acquisition
    • Ashfield Engage, Popit Form Digital Monitoring Collaboration
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • High Drug Loading Amorphous Solid Dispersions
    • Parenteral Drug Delivery Trends
    • Selecting the Right Outsourcing Model for Emerging Biotech
    • Inhaled Drug Delivery Technology
    • The Future of Biologics: Accelerating Production, Reducing Costs
    • Business Intelligence For (and From) the Lab
    • Communicating Your Contracting Priorities to Your Drug Company Customers
    • COVID-19 Impact Report
    • The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Preliminary Study Links Markers of Impaired Bone Health to Vegan Diet
    Refined Grains Linked to Heart Attack Risk, Early Death
    Kappa Bioscience Extends Research Partnership For COVID-19 Research
    Coatings World

    Latest Breaking News From Coatings World

    Nippon Paint Marine Wins Korea Export Award
    Universal Display Corporation, PPG Expand Global Production of UniversalPHOLED Materials
    PPG Introduces Premium Iso-free Primer Surfacer, Catalyst
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    January AI Raises $8.8 Million in New Funding
    FDA Clears Ava Fertility Tracking Wearable Device
    First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Spark Therapeutics Appoints CTO
    Cryoport Launches ESG Program
    U.S. Govt. Purchases 100k Doses of Lilly's COVID-19 Antibody Cocktail
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    The Top Beauty Products of 2021, According to HelloGiggles
    Estée Lauder Taps Ana de Armas as Global Brand Ambassador
    Sephora Announces Significant Expansion
    Happi

    Latest Breaking News From Happi

    ACI Urges Senate to Approve Regan as EPA Administrator
    Estée Lauder Signs Actress Ana de Armas
    GUM Recalls Oral Spray
    Ink World

    Latest Breaking News From Ink World

    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Marshall & Bruce Adds Koenig & Bauer Rapida 106 41-Inch Seven-Color Press
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    FTA converts Forum & INFOFLEX to virtual events
    Xeikon launches two new digital label printing presses
    UFlex adds capacity in packaging films
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Texas Medical Technology Partners with My Protect Kit
    Mexico City Single-Use Plastics Ban Leads to Tampon Shortage
    Believe Diapers Launch in U.S.
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System
    Kaia Health Unveils Next-Gen Complete MSK Care Solutions
    First Implantation of CTL Amedica's Minimally Invasive Flex Tower
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login